Sobi in PNH –
Our strength lies in rare diseases
At Sobi, we’re developing innovative new medicines to raise standards of care for people with paroxysmal nocturnal haemoglobinuria (PNH).
PNH is a life-threatening rare blood disorder, characterised by haemolytic anaemia, thrombosis and debilitating symptoms.1
Introducing PNH
Dr Anders Ullman, Chief Medical Officer of Sobi, provides an introduction to PNH
Partnering4PNH
Highlighting PNH unmet medical needs
Living with PNH
Diagnosing PNH can be a challenge
PNH – Unrelieved symptoms
Despite current treatments, people with PNH may still experience debilitating symptoms
PNH – When surviving isn’t enough
Transforming life for people with PNH
PNH – Mode of disease
Find out what causes PNH
References
- Hill A, DeZern AE, Kinoshita T & Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 2017;3:17028.
Abbreviations
PNH: Paroxysmal nocturnal haemoglobinuria
Job code: PP-17755 | Date of preparation: March 2023
Intended for healthcare professional only